http://www.dailypolitical.com/2016/10/02/shinko-asset-management-co-ltd-has-409000-stake-in-merck-co-mrk.html
http://www.dailypolitical.com/2016/10/02/merck-co-mrk-stake-increased-by-brick-kyle-associates.html
http://www.dailypolitical.com/2016/10/02/merck-co-mrk-stake-maintained-by-bush-odonnell-investment-advisors-inc.html
http://www.dailypolitical.com/2016/10/01/stephens-inc-ar-acquires-48185-shares-of-merck-co-mrk.html
http://www.prnewswire.com/news-releases/sun-pharma-to-announce-late-breaking-results-for-investigational-il-23p19-inhibitor-tildrakizumab-achieves-primary-end-point-in-both-phase-3-studies-in-patients-with-moderate-to-severe-plaque-psoriasis-300337601.html
http://www.4-traders.com//news/Sun-Pharma-to-Announce-Late-Breaking-Results-for-Investigational-IL-23p19-inhibitor-Tildrakizumab--23147142/
http://www.mb.com.ph/potential-new-first-line-treatment-for-lung-cancer-bared/
http://www.commondreams.org/views/2016/10/01/why-us-big-pharma-lobby-sponsoring-conference-future-health-care-canada
http://www.presseportal.de/pm/80515/3445755
http://www.prnewswire.co.uk/news-releases/eisai-enrols-patients-in-global-phase-iii-trial-to-evaluate-first-line-kisplyx-lenvatinib-plus-pembrolizumab-or-everolimus-versus-sunitinib-in-advanced-renal-cell-carcinoma1-595580051.html
http://www.finanznachrichten.de/nachrichten-2016-10/38744520-eisai-enrols-patients-in-global-phase-iii-trial-to-evaluate-first-line-kisplyx-lenvatinib-plus-pembrolizumab-or-everolimus-versus-sunitinib-in-adva-008.htm
https://www.yahoo.com/news/factbox-biosimilar-landscape-cluttered-big-pharma-lawsuits-091229927--finance.html
http://www.free-press-release-center.info/pr00000000000000358315.html
http://www.zawya.com/mena/en/multimedia/video/VIDTR_29092016220113155/
http://www.bloomberg.com/news/articles/2016-09-30/man-s-best-friend-may-be-the-flu-s-worst-enemy
http://economictimes.indiatimes.com/news/international/business/big-pharma-vs-big-pharma-in-court-battles-over-biosimilar-drugs/articleshow/54640324.cms
http://news.trust.org/item/20161002090237-6j5hd/
http://www.sheknows.com/health-and-wellness/articles/1128691/what-its-like-hypochondria
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-announces-details-of-psoriasis-drug-trials/articleshow/54629922.cms
http://www.emailwire.com/release/279270-Global-Asthma-COPD-Market-Report-2015-Edition-Key-Players-such-as-AstraZeneca-Merck-and-Co-Roche-Sanofi-and-Novartis-etc.html
http://www.dailyherald.com/article/20161001/business/161009977/
http://www.pr.com/press-release/689678
http://www.bloomberg.com/news/articles/2016-09-30/dale-b-schenk-prothena-corp-co-founder-and-ceo-dies-at-59
http://www.adnkronos.com/immediapress/pr-newswire/2016/10/03/eisai-enrols-patients-global-phase-carcinoma-trial-evaluate-first-line-kisplyx-lenvatinib-plus-pembrolizumab-everolimus-versus-sunitinib-advanced-renal-cell_8NdfjVZRKTpGC9y8NyEAVJ.html
http://www.nytimes.com/2016/10/01/health/severe-eczema-atopic-dermatitis-drug.html
